Improve access. Improve life.

The End Drug Shortages Alliance is a collaboration of select health system, supply chain, industry and other stakeholders dedicated to solving pharmaceutical supply challenges by increasing transparency. We prioritize initiatives focused on transparency, quality, redundancy and production of additional supply to achieve measured results that improve access to essential medications and improve quality of life for patients that rely on these medications.

Join like-minded organizations as part of the End Drug Shortages Alliance

Sign up

Our initiatives
  1. Transparency and redundancy
  2. Quality
  3. Production of additional supply
Learn more

 

Drug Shortages

Commitment to supply resiliency

As part of the ongoing strategy to end supply interruptions, the Vizient® team of pharmacy experts have identified essential medications that if not available, could represent the greatest threat to providing immediate and high-quality patient care. As of this edition, 15 drugs were added to the list creating a total of 265 line items, representing 251 unique drugs.

Complete the form to download and view these essential medications which are grouped in the three categories below.

  • Acute treatment drugs with no alternatives (77 drugs)
  • Chronic treatment drugs with no alternatives (37 drugs)
  • High impact drugs (151 drugs)
  • Pediatric impact (68 drugs)
  • Antibiotic resistance (28 drugs)

Many of these medications are available through the Novaplus® private label program. Access our fact sheet to learn more.

Get the updated Essential Medications report

Complete the form below to download the report

Quantifying drivers of supply chain resilience in pediatric oncology medications

Angels for Change, United States Pharmacopeia (USP) and Vizient collaborated to characterize and quantify supply chain risk for drugs to improve pediatric oncology access to quality medicines.

Download the white paper

The hidden cost of drug shortages

Between March 6 and April 4, 2019, the Vizient Drug Shortages Task Force conducted its inaugural member survey to uncover the unseen impacts of drug shortages.

Discover what hospital roles are impacted the most and gain insights into Vizient solutions that help mitigate and end drug shortages.

Download the full report to learn key strategies hospitals are using to manage drug shortages and get key insights for:

  • executives
  • pharmacy directors
  • buyers and technicians

$ 359 M

Cost of labor needed to manage drug shortages per year

8.6 M

Additional hours of labor per year

Understanding and mitigating pediatric drug shortages

Vizient pharmacy experts, in collaboration with the Children’s Hospital Association (CHA), have created a report examining the impact of drug shortages on self-governed pediatric hospitals, and the strategies employed to manage and mitigate these shortages.

 

Download the report

Connect with Vizient to find out how we can help you manage drug shortages or to learn about our other pharmacy initiatives.